515 related articles for article (PubMed ID: 30219719)
21. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms.
Sharonova T; Paramonova P; Kalinin S; Bunev A; Gasanov RЕ; Nocentini A; Sharoyko V; Tennikova TB; Dar'in D; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Jun; 218():113352. PubMed ID: 33774343
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
23. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
[TBL] [Abstract][Full Text] [Related]
24. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights.
Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164
[TBL] [Abstract][Full Text] [Related]
25. Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity.
Ibrahim HS; Abdelrahman MA; Nocentini A; Bua S; Abdel-Aziz HA; Supuran CT; Abou-Seri SM; Eldehna WM
Bioorg Chem; 2022 Sep; 126():105888. PubMed ID: 35661530
[TBL] [Abstract][Full Text] [Related]
26. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
Mboge MY; Chen Z; Wolff A; Mathias JV; Tu C; Brown KD; Bozdag M; Carta F; Supuran CT; McKenna R; Frost SC
PLoS One; 2018; 13(11):e0207417. PubMed ID: 30452451
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
[TBL] [Abstract][Full Text] [Related]
30. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
31. Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.
Kumar S; Ceruso M; Tuccinardi T; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2907-2913. PubMed ID: 27166574
[TBL] [Abstract][Full Text] [Related]
32. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
[TBL] [Abstract][Full Text] [Related]
33. Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII.
Redij A; Carradori S; Petreni A; Supuran CT; Toraskar MP
Anticancer Agents Med Chem; 2023; 23(10):1217-1223. PubMed ID: 36825712
[TBL] [Abstract][Full Text] [Related]
34. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX.
Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A
Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081
[TBL] [Abstract][Full Text] [Related]
36. 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII.
Khloya P; Celik G; SitaRam ; Vullo D; Supuran CT; Sharma PK
Eur J Med Chem; 2014 Apr; 76():284-90. PubMed ID: 24589484
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
[TBL] [Abstract][Full Text] [Related]
38. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
39. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.
Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT
Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856
[TBL] [Abstract][Full Text] [Related]
40. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
